GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **51 - 75** of **4050** in total

« First

‹ Prev

1

2

3

4

5

6

7

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▼	Arbitrary Fluorescence Units (AFU)
IgG	Patient 3	-180	mild	G98240FC	54
IgM	Patient 3	-180	mild	G98240FC	72
IgA	Patient 3	4	mild	G98240FC	506
IgG	Patient 3	11	mild	G98240FC	118
IgG	Patient 3	4	mild	G98240FC	125
IgM	Patient 3	11	mild	G98240FC	235
IgM	Patient 3	4	mild	G98240FC	290
IgA	Patient 4	12	mild	G98240FC	489
IgG	Patient 4	12	mild	G98240FC	455
IgM	Patient 4	12	mild	G98240FC	341
IgA	Patient 1	10	moderate	G98068PA	383
IgA	Patient 1	22	moderate	G98068PA	351
IgA	Patient 1	6	moderate	G98068PA	291
IgG	Patient 1	10	moderate	G98068PA	22
IgG	Patient 1	22	moderate	G98068PA	27
IgM	Patient 1	10	moderate	G98068PA	34
IgM	Patient 1	22	moderate	G98068PA	98
IgG	Patient 1	6	moderate	G98068PA	24
IgM	Patient 1	6	moderate	G98068PA	39
IgA	Patient 2	15	mild	G98068PA	447
IgA	Patient 2	24	mild	G98068PA	484
IgG	Patient 2	15	mild	G98068PA	38
IgG	Patient 2	24	mild	G98068PA	38
IgM	Patient 2	15	mild	G98068PA	121
IgA	Patient 2	3	mild	G98068PA	501